ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
Hao LiuHui LyuGuanmin JiangDanyang ChenSanbao RuanShuang LiuLukun ZhouMinqiang YangShanshan ZengZhi-Min HeHong-Sheng WangHong-Sheng LiGuopei ZhengXiaolong LiuPublished in: Cancer research (2022)
GLUT4 upregulation by ALKBH5-mediated m6A demethylation induces glycolysis and resistance to HER2-targeted therapy and represents a potential therapeutic target for treating HER2-positive breast cancer.